Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up

AIDS

Volumn 23, Issue 13, 2009, Pages 1786-1789

  Ndiaye, Bakhao ^a,b,h   Ould Kaci, Karim ^a   Salleron, Julia ^b   Bataille, Pierre ^c,h   Bonnevie, Frederique ^d,h   Cochonat, Karine ^e,h   Fontier, Clotilde ^f,h   Guerroumi, Habib ^g   Yazdanpanah, Yazdan ^b,g,h  

^a CIRE Nord   (France)

^b UNIV LILLE   (France)

^c CH Boulogne   (France)

^d CH Dunkerque   (France)

^e Centre Hospitalier de LENS   (France)

^f CENTRE HOSPITALIER DE VALENCIENNES   (France)

^g Service Universitaire des Maladies Infectieuses et du Voyageur   (France)

^h COREVIH Nord Pas de Calais ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PATIENT CARE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; CD4 LYMPHOCYTE COUNT; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; LONG-TERM CARE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 69449093803     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832e3469     Document Type: Article

References (16)

1. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-129. (Pubitemid 34786200)
2. Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 1999; 160:659-665. (Pubitemid 29149796)
3. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352:1725-1730. (Pubitemid 28534954)
4. Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al. Long-termeffectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366:378-384. (Pubitemid 41073955)
5. Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, Chersich MF, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa. J Acquir Immune Defic Syndr 2008; 47:101-107. (Pubitemid 351619376)
6. Maskew M, MacPhail P, Menezes C, Rubel D. Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J 2007; 97:853-857. (Pubitemid 47542654)
7. Lebouche B, Yazdanpanah Y, Gerard Y, Sissoko D, Ajana F, Alcaraz I, et al. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med 2006; 7:140-145.
8. Nacher M, El GM, Vaz T, Nasser V, Randrianjohany A, Alvarez F, et al. Risk factors for follow-up interruption of HIV patients in French Guiana. Am J Trop Med Hyg 2006; 74:915-917. (Pubitemid 46774417)
9. Lanoy E, Mary-Krause M, Tattevin P, Dray-Spira R, Duvivier C, Fischer P, et al. Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol 2006; 59:829-835.
10. Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, et al. Loss to follow-up in an international, multicentre observational study. HIV Med 2008; 9:261-269.
11. Ndiaye B, Ould-Kaci K, Bataille P, Bonnevie F, Choisy P, Cochonat K, et al. Incidence rate and risk factors for loss to follow-up in five French clinical centres of HIV-infected patients in Northern France - January 1997 to December 2006. Antivir Ther 2009 [Epub ahead of print].
12. Cox DR. Regression models and life tables (with discussion). J R Statist Soc B 1972; 269-276.
13. Cohen CJ, Iwane MK, Palensky JB, Levin DL, Meagher KJ, Frost KR, et al. A national HIV community cohort: design, baseline, and follow-up of the AmFAR Observational Database. American Foundation for AIDS Research Community-Based Clinical Trials Network. J Clin Epidemiol 1998; 51:779-793.
14. Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46:S3-S8. (Pubitemid 47312320)
15. Lanoy E, Mary-Krause M, Tattevin P, Perbost I, Poizot-Martin I, Dupont C, et al. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007; 12:89-96. (Pubitemid 46340430)
16. Castilla J, Del RJ, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 2005; 40:96-101. (Pubitemid 41233212)